- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer - Abstract
February 23, 2011
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer - Abstract
February 23, 2011
Testicular metastases from prostate cancer - Abstract
February 23, 2011
Cost-effectiveness of prostate specific antigen screening in the United States: Extrapolating from the European Study of Screening for Prostate Cancer - Abstract
February 22, 2011
Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer - Abstract
February 22, 2011
Assessing the acceptability and usability of an interactive serious game in aiding treatment decisions for patients with localized prostate cancer - Abstract
February 22, 2011
Prostate cancer screening and informed decision-making: Provider and patient perspectives - Abstract
February 22, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Overview of translational aspects of drug development in prostate cancer - Session Highlights
February 22, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Immune targeting in prostate cancer - Session Highlights
February 22, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Aspects of the androgen receptor pathway in prostate cancer - Session Highlights
February 22, 2011
A case of robot-assisted laparoscopic radical prostatectomy in primary small cell prostate cancer - Abstract
February 21, 2011
Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: Late toxicity - Abstract
February 21, 2011
Evaluation of prostate specific antigen acceleration for prostate cancer diagnosis - Abstract
February 21, 2011